UBS AM’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,154
| Closed | -$12.9K | – | 2671 |
|
|
2025
Q1 | $12.9K | Buy |
+2,154
| New | +$12.9K | ﹤0.01% | 2628 |
|
|
2024
Q4 | – | Sell |
-56,507
| Closed | -$577K | – | 2711 |
|
|
2024
Q3 | $577K | Sell |
56,507
-2,333
| -4% | -$23.8K | ﹤0.01% | 2609 |
|
|
2024
Q2 | $873K | Buy |
58,840
+15,585
| +36% | +$231K | ﹤0.01% | 2446 |
|
|
2024
Q1 | $590K | Hold |
43,255
| – | – | ﹤0.01% | 2234 |
|
|
2023
Q4 | $474K | Hold |
43,255
| – | – | ﹤0.01% | 2337 |
|
|
2023
Q3 | $474K | Buy |
43,255
+18,094
| +72% | +$198K | ﹤0.01% | 2320 |
|
|
2023
Q2 | $342K | Hold |
25,161
| – | – | ﹤0.01% | 2435 |
|
|
2023
Q1 | $342K | Buy |
25,161
+4,024
| +19% | +$54.8K | ﹤0.01% | 2435 |
|
|
2022
Q4 | $413K | Buy |
+21,137
| New | +$413K | ﹤0.01% | 2248 |
|
|
2022
Q2 | – | Sell |
-6,700
| Closed | -$216K | – | 2729 |
|
|
2022
Q1 | $216K | Buy |
+6,700
| New | +$216K | ﹤0.01% | 2663 |
|